Search - tctmd.com

Displaying 181 - 200 of 240

Sort: Relevancy | Date

News Conference News ACC 2012

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

Yael L. Maxwell

April 02, 2012

News Conference News ACC 2012

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

March 26, 2012

News Daily News

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

Caitlin E. Cox

March 25, 2012

News Conference News ACC 2012

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

March 24, 2012

News Daily News

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

Leah Lawrence

March 23, 2012

News Daily News

BARC Criteria Validated Against Existing Bleeding Definitions

Leah Lawrence

March 23, 2012

News Daily News

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

March 22, 2012

News Daily News

El Índice Hemodinámico Ayuda a Definir el Impacto de la Regurgitación Aórtica Tras la TAVR

March 21, 2012

News Daily News

SES Effective for Both Focal, Diffuse DES Restenosis

March 13, 2012

News Daily News

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Yael L. Maxwell

March 06, 2012

News Daily News

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

L.A. McKeown

March 04, 2012

News Daily News

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

February 21, 2012

News Daily News

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

January 24, 2012

News Daily News

Fewer Vascular Complications as TAVR Evolves

Caitlin E. Cox

January 10, 2012

Presentation TCT 2012

Reconsidering Outcomes After Transcatheter Aortic Valve Implantation Following The Valve Academic Research Consortium Definitions

Presenter: Moritz Seiffert

January 03, 2012

News Daily News

Repositionable Valve Yields Promising 2-Year TAVR Results

December 06, 2011

News Conference News

Complications After TAVR: Manageable, But Important to Consider

November 09, 2011

News Industry News

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

November 07, 2011

News Daily News

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

October 17, 2011

News Daily News

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

October 03, 2011

Advertisement

ACC-i2 Scientific Session 2012: Cooperation Key as Practice Changing Results Released

RESOLUTE: Zotarolimus-Eluting Stent Fares Well at 2 Years

Meta-Analysis: Cobalt-Chromium EES Cut Stent Thrombosis Compared with BMS, Other DES

ADVANCE: TAVR with CoreValve Safe, Effective at 6 Months

Los Criterios del BARC Validados frente a las Definiciones Hemorrágicas Existentes

BARC Criteria Validated Against Existing Bleeding Definitions

IABP Use Most Risky in ACS Patients Undergoing Urgent PCI

El Índice Hemodinámico Ayuda a Definir el Impacto de la Regurgitación Aórtica Tras la TAVR

SES Effective for Both Focal, Diffuse DES Restenosis

Stent Thrombosis Risk Lower with Xience vs. First-Generation DES

Registry Study: One-Year Outcomes Similar for TAVR, Surgery

EVOLVE Published: Bioabsorbable EES Matches Permanent-Polymer Version

NEXT Up: Polymer-Free SES Angiographically Superior to Taxus

Fewer Vascular Complications as TAVR Evolves

Reconsidering Outcomes After Transcatheter Aortic Valve Implantation Following The Valve Academic Research Consortium Definitions

Repositionable Valve Yields Promising 2-Year TAVR Results

Complications After TAVR: Manageable, But Important to Consider

Medtronic Resolute(R) Drug-Eluting Stent Shows Strong Results, Even in Challenging Diabetes Patients with Coronary Disease

Xience Shows Noninferior Late Loss to Cypher, Similar Hard Outcomes

CoreValve Appears a Feasible Replacement for Failed Surgical Aortic Valves

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content